Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells

OncoImmunology

Volumn 3, Issue 4, 2014, Pages

  Calvet, Christophe Y ^a,b   Famin, Delphine ^a,b   André, Franck M ^a,b   Mir, Lluis M ^a,b  

^a France   (France)

^b CNRS   (France)

Author keywords

ATP; Bleomycin; Calreticulin; Electrochemotherapy; Electroporation; HMGB1; Immunogenic cell death; Immunotherapy; Vaccination

Indexed keywords

ADENOSINE TRIPHOSPHATE; BLEOMYCIN; CALRETICULIN; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL DESTRUCTION; CANCER CELL LINE; CANCER IMMUNIZATION; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; ELECTROCHEMOTHERAPY; IMMUNOCOMPETENCE; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN SECRETION;

EID: 84902603341     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28131     Document Type: Article

References (65)

1. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immunol-032712-100008
2. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12:860-75; PMID:23151605; http://dx.doi.org/10.1038/nrc3380
3. Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, Séror C, Métivier D, Perfettini JL, Zitvogel L, et al. Chemotherapy induces ATP release from tumor cells. Cell Cycle 2009; 8:3723-8; PMID:19855167; http://dx.doi.org/10.4161/cc.8.22.10026
4. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10.1126/science.1208347
5. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461:282-6; PMID:19741708; http://dx.doi.org/10.1038/nature08296
6. Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, et al. ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology 2013; 2:e24568; PMID:23894718; http://dx.doi.org/10.4161/onci.24568
7. Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med 2011; 208:491-503; PMID:21383056; http://dx.doi.org/10.1084/jem.20100269
8. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
9. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, et al. Mechanisms of preapoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28:578-90; PMID:19165151; http://dx.doi.org/10.1038/emboj.2009.1
10. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 2012; 1:786-8; PMID:22934283; http://dx.doi.org/10.4161/onci.19750
11. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi.org/10.1038/nm1523
12. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM. Cellsurface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123:321-34; PMID:16239148; http://dx.doi.org/10.1016/j.cell.2005.08.032
13. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191-5; PMID:12110890; http://dx.doi.org/10.1038/nature00858
14. Chen G, Ward MF, Sama AE, Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res 2004; 24:329-33; PMID:15212706; http://dx.doi.org/10.1089/107999004323142187
15. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192:565-70; PMID:10952726; http://dx.doi.org/10.1084/jem.192.4.565
16. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622
17. Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr., Schwaab G, Luboinski B, Paoletti C. [Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III 1991; 313:613-8; PMID:1723647
18. Breton M, Mir LM. Microsecond and nanosecond electric pulses in cancer treatments. Bioelectromagnetics 2011; 33:106-23; PMID:21812011; http://dx.doi.org/10.1002/bem.20692
19. Escoffre JM, Rols MP. Electrochemotherapy: progress and prospects. Curr Pharm Des 2012; 18:3406-15; PMID:22663554; http://dx.doi.org/10.2174/138161212801227087
20. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, Geertsen PF, Rudolf Z, O'Sullivan GC, Marty M. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or noninvasive electrodes. Ejc Suppl 2006; 4:14-25; http://dx.doi.org/10.1016/j.ejcsup.2006.08.003
21. Gehl J, Sersa G, Garbay J, Soden D, Rudolf Z, Marty M, O'Sullivan G, Geertsen PF, Mir LM. Results of the ESOPE (European Standard Operating Procedures on Electrochemotherapy) study: Efficient, highly tolerable and simple palliative treatment of cutaneous and subcutaneous metastases from cancers of any histology. J Clin Oncol 2006; 24(Suppl):s8047
22. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992; 3:331-4; PMID:1379837
23. Sersa G, Miklavcic D, Cemazar M, Belehradek J, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem Bioenerg 1997; 43:279-83; http://dx.doi.org/10.1016/S0302-4598(96)05194-X
24. Mir LM, Orlowski S, Belehradek J Jr., Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27:68-72; PMID:1707289; http://dx.doi.org/10.1016/0277-5379(91)90064-K
25. Gerlini G, Sestini S, Di Gennaro P, Urso C, Pimpinelli N, Borgognoni L. Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 2013; 30:37-45; PMID:22735940; http://dx.doi.org/10.1007/s10585-012-9505-1
26. Roux S, Bernat C, Al-Sakere B, Ghiringhelli F, Opolon P, Carpentier AF, Zitvogel L, Mir LM, Robert C. Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responses. Cancer Immunol Immunother 2008; 57:1291-300; PMID:18259749; http://dx.doi.org/10.1007/s00262-008-0462-0
27. Mekid H, Tounekti O, Spatz A, Cemazar M, El Kebir FZ, Mir LM. In vivo evolution of tumour cells after the generation of double-strand DNA breaks. Br J Cancer 2003; 88:1763-71; PMID:12771993; http://dx.doi.org/10.1038/sj.bjc.6600959
28. Sersa G, Kotnik V, Cemazar M, Miklavcic D, Kotnik A. Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice--natural resistance and immune responsiveness. Anticancer Drugs 1996; 7:785-91; PMID:8949991; http://dx.doi.org/10.1097/00001813-199609000-00011
29. Roth C, Mir LM, Cressent M, Quintin-Colonna F, Belehradek J Jr., Ley V, Fradelizi D, Kourilsky P. [Inhibition of the tumoral growth induced by the injection of histo-incompatible cells producing interleukin-2]. C R Acad Sci III 1992; 314:499-504; PMID:1521169
30. Mir LM, Roth C, Orlowski S, Belehradek J Jr., Fradelizi D, Paoletti C, Kourilsky P. [Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2]. C R Acad Sci III 1992; 314:539-44; PMID:1381659
31. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr., Kourilsky P. Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother Emphasis Tumor Immunol 1995; 17:30-8; PMID:7537154; http://dx.doi.org/10.1097/00002371-199501000-00004
32. Orlowski S, An D, Belehradek J Jr., Mir LM. Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2-secreting cells in the murine Lewis lung tumor. Anticancer Drugs 1998; 9:551-6; PMID:9877244; http://dx.doi.org/10.1097/00001813-199807000-00006
33. Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J Jr., Munck JN, Mir LM. Electrochemotherapy on liver tumours in rabbits. Br J Cancer 1998; 77:2104-11; PMID:9649121; http://dx.doi.org/10.1038/bjc.1998.354
34. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997; 186:1623-31; PMID:9362523; http://dx.doi.org/10.1084/jem.186.10.1623
35. Orlowski S, Belehradek J Jr., Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37:4727-33; PMID:2462423; http://dx.doi.org/10.1016/0006-2952(88)90344-9
36. Poddevin B, Orlowski S, Belehradek J Jr., Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 1991; 42(Suppl):S67-75; PMID:1722669; http://dx.doi.org/10.1016/0006-2952(91)90394-K
37. Teissie J, Golzio M, Rols MP. Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of? ) knowledge. Biochim Biophys Acta 2005; 1724:270-80; PMID:15951114; http://dx.doi.org/10.1016/j.bbagen.2005.05.006
38. Soden DM, Larkin JO, Collins CG, Tangney M, Aarons S, Piggott J, Morrissey A, Dunne C, O'Sullivan GC. Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett 2006; 232:300-10; PMID:15964138; http://dx.doi.org/10.1016/j.canlet.2005.03.057
39. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9:10; PMID:20178589; http://dx.doi.org/10.1186/1475-925X-9-10
40. Mahmood F, Gehl J. Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochemistry 2011; 81:10-6; PMID:21256816; http://dx.doi.org/10.1016/j.bioelechem.2010.12.002
41. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, Gehl J. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 2011; 71:3753-62; PMID:21507935; http://dx.doi.org/10.1158/0008-5472.CAN-11-0451
42. Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, Mali B, Jarm T, Pavliha D, Marcan M, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011; 10:475-85; PMID:21895032
43. Fini M, Salamanna F, Parrilli A, Martini L, Cadossi M, Maglio M, Borsari V. Electrochemotherapy is effective in the treatment of rat bone metastases. Clin Exp Metastasis 2013; 30:1033-45; PMID:23832763; http://dx.doi.org/10.1007/s10585-013-9601-x
44. Jahangeer S, Forde P, Soden D, Hinchion J. Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours. Cancer Treat Rev 2013; 39:862-71; PMID:23601905; http://dx.doi.org/10.1016/j.ctrv.2013.03.007
45. Bugaut H, Bruchard M, Berger H, Derangère V, Odoul L, Euvrard R, Ladoire S, Chalmin F, Végran F, Rébé C, et al. Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells. PLoS One 2013; 8:e65181; PMID:23762310; http://dx.doi.org/10.1371/journal.pone.0065181
46. Pron G, Mahrour N, Orlowski S, Tounekti O, Poddevin B, Belehradek J Jr., Mir LM. Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol 1999; 57:45-56; PMID:9920284; http://dx.doi.org/10.1016/S0006-2952(98)00282-2
47. Pron G, Belehradek J Jr., Orlowski S, Mir LM. Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol 1994; 48:301-10; PMID:7519854; http://dx.doi.org/10.1016/0006-2952(94)90101-5
48. Pron G, Belehradek J Jr., Mir LM. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun 1993; 194:333-7; PMID:7687434; http://dx.doi.org/10.1006/bbrc.1993.1824
49. Esser AT, Smith KC, Gowrishankar TR, Vasilkoski Z, Weaver JC. Mechanisms for the intracellular manipulation of organelles by conventional electroporation. Biophys J 2010; 98:2506-14; PMID:20513394; http://dx.doi.org/10.1016/j.bpj.2010.02.035
50. Skolucka N, Daczewska M, Saczko J, Chwilkowska A, Choromanska A, Kotulska M, Kaminska I, Kulbacka J. ETM study of electroporation influence on cell morphology in human malignant melanoma and human primary gingival fibroblast cells. Asian Pac J Trop Biomed 2011; 1:94-8; PMID:23569735; http://dx.doi.org/10.1016/S2221-1691(11)60003-8
51. Benov LC, Antonov PA, Ribarov SR. Oxidative damage of the membrane lipids after electroporation. Gen Physiol Biophys 1994; 13:85-97; PMID:7806071
52. Gabriel B, Teissié J. Generation of reactive-oxygen species induced by electropermeabilization of Chinese hamster ovary cells and their consequence on cell viability. Eur J Biochem 1994; 223:25-33; PMID:8033899; http://dx.doi.org/10.1111/j.1432-1033.1994.tb18962.x
53. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a doubleedged sword? Antioxid Redox Signal 2007; 9:2277-93; PMID:17979528; http://dx.doi.org/10.1089/ars.2007.1782
54. Garg AD, Martin S, Golab J, Agostinis P. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death 2014; 21:26-38; PMID:23686135; http://dx.doi.org/10.1038/cdd.2013.48
55. Glogauer M, Lee W, McCulloch CA. Induced endocytosis in human fibroblasts by electrical fields. Exp Cell Res 1993; 208:232-40; PMID:8359218; http://dx.doi.org/10.1006/excr.1993.1242
56. Rols MP, Femenia P, Teissie J. Long-lived macropinocytosis takes place in electropermeabilized mammalian cells. Biochem Biophys Res Commun 1995; 208:26-35; PMID:7887937; http://dx.doi.org/10.1006/bbrc.1995.1300
57. Rols MP, Teissié J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 1990; 58:1089-98; PMID:2291935; http://dx.doi.org/10.1016/S0006-3495(90)82451-6
58. Hojman P, Gissel H, Andre FM, Cournil-Henrionnet C, Eriksen J, Gehl J, Mir LM. Physiological effects of high- and low-voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther 2008; 19:1249-60; PMID:19866489; http://dx.doi.org/10.1089/hum.2008.059
59. Grønevik E, Mathiesen I, Lømo T. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J Gene Med 2005; 7:1246-54; PMID:15822067; http://dx.doi.org/10.1002/jgm.760
60. Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM, Signori E. Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 2008; 8:1645-57; PMID:18847301; http://dx.doi.org/10.1517/14712598.8.11.1645
61. Peng B, Zhao Y, Xu L, Xu Y. Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity. Vaccine 2007; 25:2064-73; PMID:17239494; http://dx.doi.org/10.1016/j.vaccine.2006.11.042
62. Alison MR, Lim SM, Nicholson LJ. Cancer stem cells: problems for therapy? J Pathol 2011; 223:147-61; PMID:21125672; http://dx.doi.org/10.1002/path.2793
63. Ledur PF, Villodre ES, Paulus R, Cruz LA, Flores DG, Lenz G. Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells. Purinergic Signal 2012; 8:39-48; PMID:21818572; http://dx.doi.org/10.1007/s11302-011-9252-9
64. Inoda S, Hirohashi Y, Torigoe T, Morita R, Takahashi A, Asanuma H, Nakatsugawa M, Nishizawa S, Tamura Y, Tsuruma T, et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am J Pathol 2011; 178:1805-13; PMID:21435460; http://dx.doi.org/10.1016/j.ajpath.2011.01.004
65. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228-47; PMID:19097774; http://dx.doi.org/10.1016/j.ejca.2008.10.026